AT250975B - Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b, f][1, 4] oxazepine - Google Patents

Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b, f][1, 4] oxazepine

Info

Publication number
AT250975B
AT250975B AT973665A AT973665A AT250975B AT 250975 B AT250975 B AT 250975B AT 973665 A AT973665 A AT 973665A AT 973665 A AT973665 A AT 973665A AT 250975 B AT250975 B AT 250975B
Authority
AT
Austria
Prior art keywords
oxazepines
new
production
basic substituted
substituted dibenz
Prior art date
Application number
AT973665A
Other languages
English (en)
Inventor
Jean Dr Schmutz
Fritz Dr Hunziker
Franz Martin Kuenzle
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Application granted granted Critical
Publication of AT250975B publication Critical patent/AT250975B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT973665A 1964-05-27 1965-05-26 Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b, f][1, 4] oxazepine AT250975B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH676263A CH436297A (de) 1964-05-27 1964-05-27 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b, f)-(1,4)oxazepine

Publications (1)

Publication Number Publication Date
AT250975B true AT250975B (de) 1966-12-12

Family

ID=4314640

Family Applications (3)

Application Number Title Priority Date Filing Date
AT455864A AT258912B (de) 1964-05-27 1964-05-26 Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz [b,f] [1,4]oxazepine
AT973765A AT252925B (de) 1964-05-27 1964-05-26 Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f][1,4]oxazepine
AT973665A AT250975B (de) 1964-05-27 1965-05-26 Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b, f][1, 4] oxazepine

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT455864A AT258912B (de) 1964-05-27 1964-05-26 Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz [b,f] [1,4]oxazepine
AT973765A AT252925B (de) 1964-05-27 1964-05-26 Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f][1,4]oxazepine

Country Status (2)

Country Link
AT (3) AT258912B (de)
CH (1) CH436297A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890919B2 (en) 2001-06-26 2005-05-10 Shitij Kapur Atypical antipsychotic agents having low affinity for the D2 receptor
NZ540207A (en) * 2002-11-26 2008-06-30 Alexza Pharmaceuticals Inc Loxapine (2-chloro-11(4-methyl-1-piperazinyl)dibenz(b, f) (1,4) oxazepine) for the manufacture of a medicament for the treatment of headache
WO2004104492A2 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
NZ547911A (en) 2003-12-22 2010-06-25 Acadia Pharm Inc Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device
EP4428132A1 (de) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack aktivierende verbindungen und ihre medizinische verwendung
WO2024184543A1 (en) * 2023-03-08 2024-09-12 Johann Wolfgang Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use

Also Published As

Publication number Publication date
AT252925B (de) 1967-03-10
CH436297A (de) 1967-05-31
AT258912B (de) 1967-12-27

Similar Documents

Publication Publication Date Title
AT252925B (de) Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f][1,4]oxazepine
CH470345A (de) Verfahren zur Herstellung neuer Styryläthanolamine
CH460033A (de) Verfahren zur Herstellung neuer Diazepin-Derivate
CH446340A (de) Verfahren zur Herstellung neuer Phenthiazinderivate
CH513898A (de) Verfahren zur Herstellung neuer Schwefel-Verbindungen von 1,2-Dithiol-3-onen
AT247359B (de) Verfahren zur Herstellung von neuen, 10-basisch substituierten Dibenz[b,f][1,4] oxazepinonen
AT252926B (de) Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f][1,4]oxazepine
CH467789A (de) Verfahren zur Herstellung neuer Diazepin-Derivate
AT268521B (de) Verfahren zur Herstellung des neuen Antibiotikums Ivomycin
CH517769A (de) Verfahren zur Herstellung neuer Dibenz(b,f)(1,4)oxazepin-Derivate
AT256848B (de) Verfahren zur Herstellung neuer Oxepinderivate
CH474535A (de) Verfahren zur Herstellung neuer Oxazepine
CH467800A (de) Verfahren zur Herstellung neuer Diazepin-Derivate
CH467788A (de) Verfahren zur Herstellung neuer Diazepin-oxide
CH454859A (de) Verfahren zur Herstellung neuer Oxazepine
CH476752A (de) Verfahren zur Herstellung neuer Oxazepine
AT252923B (de) Verfahren zur Herstellung neuer Azepinderivate
AT258914B (de) Verfahren zur Herstellung von neuen 2,3,4,5-Tetrahydro-1,4-methano-1H-3-benzazepinen
AT256857B (de) Verfahren zur Herstellung von neuen Azepinderivaten
CH454862A (de) Verfahren zur Herstellung neuer Oxazepine
AT270100B (de) Verfahren zur Herstellung neuer 1,2α-Methylensteroide
CH484086A (de) Verfahren zur Herstellung neuer 1,2B-Methylensteroide
CH444174A (de) Verfahren zur Herstellung neuer Ergolen-Derivate
CH455132A (de) Verfahren zur Herstellung textiler Filamente
CH457456A (de) Verfahren zur Herstellung von neuen Diazepin-Derivaten